Subject
Cancer Research,Oncology,General Medicine
Reference17 articles.
1. A Randomized Open-Label Phase III Study of a 28 Day Oral Regimen of 5-Fluorouracil Plus 776C85 Versus Intravenous 5-Fluorouracil Plus Leucovorin as First-Line Therapy in Patients with Metastatic/Advanced Colorectal Carcinoma. FUMA 3008
2. Pharmacokinetic Modulation of 5-Fluorouracil: Emulating Continuous Infusion?